Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation.
participant focus group
pharmacist
qualitative
randomized controlled trials
vulnerable population
Journal
Health expectations : an international journal of public participation in health care and health policy
ISSN: 1369-7625
Titre abrégé: Health Expect
Pays: England
ID NLM: 9815926
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
01
06
2020
revised:
01
09
2020
accepted:
02
09
2020
pubmed:
14
10
2020
medline:
10
8
2021
entrez:
13
10
2020
Statut:
ppublish
Résumé
The Assessing outcomes of enhanced Chronic disease Care through patient Education and a value-baSed formulary Study (ACCESS) is a randomized controlled trial evaluating two interventions targeting barriers to care among those at high risk of cardiovascular disease: copayment elimination for cardioprotective medications, and a tailored self-management support programme. We designed a process evaluation to better understand participant perspectives on the interventions. We used a qualitative descriptive study design, collecting patient and pharmacist feedback via individual semi-structured telephone interviews and in-person focus groups. Data were analysed inductively using thematic analysis. Fifty-three patients (39 interviews and 14 in two focus groups) and 20 pharmacists participated. Copayment elimination provided quality of life benefits: minimizing the need to 'cut-back', allowing 'peace of mind' and providing emotional support. Health-related benefits included: improving adherence to covered medications, and helping to afford non-covered goods. The only criticism was that not all medications and testing supplies were covered. Patients reported that the educational materials provided helpful information, acted as a reminder, improved confidence, improved adherence to medication, and helped initiate conversations with providers about indicated medication. Some participants felt that the educational materials were repetitive, overly medication-focused and not tailored enough. Pharmacists felt that their patients benefitted from both interventions, which improved patient adherence and communication with their patients. The success of interventions intended to change behaviour is largely dependent upon participant's feelings that the intervention is helpful. This process evaluation provided insights into participants' perceptions on these interventions. Reception of both was largely positive with a few criticisms noted.
Sections du résumé
BACKGROUND
The Assessing outcomes of enhanced Chronic disease Care through patient Education and a value-baSed formulary Study (ACCESS) is a randomized controlled trial evaluating two interventions targeting barriers to care among those at high risk of cardiovascular disease: copayment elimination for cardioprotective medications, and a tailored self-management support programme. We designed a process evaluation to better understand participant perspectives on the interventions.
DESIGN
We used a qualitative descriptive study design, collecting patient and pharmacist feedback via individual semi-structured telephone interviews and in-person focus groups. Data were analysed inductively using thematic analysis.
RESULTS
Fifty-three patients (39 interviews and 14 in two focus groups) and 20 pharmacists participated. Copayment elimination provided quality of life benefits: minimizing the need to 'cut-back', allowing 'peace of mind' and providing emotional support. Health-related benefits included: improving adherence to covered medications, and helping to afford non-covered goods. The only criticism was that not all medications and testing supplies were covered. Patients reported that the educational materials provided helpful information, acted as a reminder, improved confidence, improved adherence to medication, and helped initiate conversations with providers about indicated medication. Some participants felt that the educational materials were repetitive, overly medication-focused and not tailored enough. Pharmacists felt that their patients benefitted from both interventions, which improved patient adherence and communication with their patients.
CONCLUSION
The success of interventions intended to change behaviour is largely dependent upon participant's feelings that the intervention is helpful. This process evaluation provided insights into participants' perceptions on these interventions. Reception of both was largely positive with a few criticisms noted.
Identifiants
pubmed: 33047417
doi: 10.1111/hex.13133
pmc: PMC7752191
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1485-1501Informations de copyright
© 2020 The Authors. Health Expectations published by John Wiley & Sons Ltd.
Références
Circulation. 2009 Mar 17;119(10):1442-52
pubmed: 19289649
J Pharm Pract. 2020 Aug;33(4):415-419
pubmed: 30518289
Medicine (Baltimore). 2016 Dec;95(49):e5561
pubmed: 27930562
BMJ Open. 2013 Jun 20;3(6):
pubmed: 23794542
Res Nurs Health. 2000 Aug;23(4):334-40
pubmed: 10940958
PLoS One. 2014 Mar 25;9(3):e89168
pubmed: 24667163
Health Aff (Millwood). 2010 Nov;29(11):2002-8
pubmed: 21041739
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Circ Cardiovasc Qual Outcomes. 2017 Jun;10(6):
pubmed: 28630370
Trials. 2019 Oct 7;20(1):577
pubmed: 31590686
Am J Manag Care. 2015 Oct;21(10):696-704
pubmed: 26633094
J Hum Lact. 2019 May;35(2):220-222
pubmed: 30849272
Health Rep. 2014 May;25(5):3-12
pubmed: 24850391
Ann Fam Med. 2007 Sep-Oct;5(5):395-402
pubmed: 17893380
CMAJ Open. 2017 Nov 22;5(4):E808-E813
pubmed: 29180377
CMAJ Open. 2014 Mar 07;2(1):E27-34
pubmed: 25077122
PLoS One. 2014 Apr 10;9(4):e94007
pubmed: 24722618
Heart Lung. 2014 Mar-Apr;43(2):133-9
pubmed: 24373484
Can J Diabetes. 2018 Apr;42 Suppl 1:S36-S41
pubmed: 29650109
Implement Sci. 2016 Sep 26;11(1):131
pubmed: 27671037
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Am J Manag Care. 2014 Jun;20(6):e229-41
pubmed: 25326932
Circulation. 2013 Sep 10;128(11 Suppl 1):S219-25
pubmed: 24030410
J Health Commun. 2015;20(9):1067-83
pubmed: 26165846
N Engl J Med. 2011 Dec 1;365(22):2088-97
pubmed: 22080794
Trials. 2014 Jun 09;15:215
pubmed: 24913438
Med Care. 1999 Jan;37(1):5-14
pubmed: 10413387
JAMA. 2002 Nov 20;288(19):2469-75
pubmed: 12435261
BMC Med. 2017 Feb 15;15(1):33
pubmed: 28196524
Int J Nurs Stud. 2007 Aug;44(6):1064-70
pubmed: 16844128
Heart. 2014 May;100(10):770-4
pubmed: 24436219
J Diabetes Sci Technol. 2013 Jan 01;7(1):111-8
pubmed: 23439166
Lancet. 2012 Jun 16;379(9833):2252-61
pubmed: 22683130
Am J Health Behav. 2007 Sep-Oct;31 Suppl 1:S69-78
pubmed: 17931139
Health Expect. 2020 Dec;23(6):1485-1501
pubmed: 33047417
BMC Cardiovasc Disord. 2019 Mar 15;19(1):62
pubmed: 30876393